Author:
Fu Yibing,Chen Jing,Pang Bo,Li Chunyan,Zhao Jing,Shen Keng
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biochemistry,General Medicine,Biophysics
Reference17 articles.
1. Rescigno, P., Cerillo, I., Ruocco, R., Condello, C., De Placido, S., & Pensabene, M. (2013). New hypothesis on pathogenesis of ovarian cancer lead to future tailored approaches. BioMed Research International,
2013, 852839.
2. Chase, A., & Cross, N. C. (2011). Aberrations of EZH2 in cancer. Clinical Cancer Research,
17, 2613–2618.
3. Li, H., & Zhang, R. (2013). Role of EZH2 in epithelial ovarian cancer: from biological insights to therapeutic target. Frontiers in Oncology,
3, 47.
4. Lu, C., Han, H. D., Mangala, L. S., Ali-Fehmi, R., Newton, C. S., Ozbun, L., et al. (2010). Regulation of tumor angiogenesis by EZH2. Cancer Cell,
18, 185–197.
5. Seward, S., Semaan, A., Qazi, A. M., Gruzdyn, O. V., Chamala, S., Bryant, C. C., et al. (2013). EZH2 blockade by RNA interference inhibits growth of ovarian cancer by facilitating re-expression of p21(waf1/cip1) and by inhibiting mutant p53. Cancer Letters,
336, 53–60.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献